1. Semenza, G.L. Regulation of Metabolism by Hypoxia-Inducible Factor 1. Cold Spring Harb. Symp. Quant. Biol. 2011, 76, 347–353. [CrossRef] [PubMed]
2. Ozaki, H.; Yu, A.Y.; Della, N.; Ozaki, K.; Luna, J.D.; Yamada, H.; Hackett, S.F.; Okamoto, N.; Zack, D.J.; Semenza, G.L.; et al. Hypoxia inducible factor-1α is increased in ischemic retina: Temporal and spatial correlation with VEGF expression. Investig. Ophthalmol. Vis. Sci. 1999, 40, 182–189.
3. Tezel, G.; Wax, M.B. Hypoxia-inducible factor 1α in the glaucomatous retina and optic nerve head. Arch. Ophthalmol. 2004, 122, 1348–1356. [CrossRef] [PubMed]
4. Rapisarda, A.; Uranchimeg, B.; Scudiero, D.A.; Selby, M.; Sausville, E.A.; Shoemaker, R.H.; Melillo, G. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway. Cancer Res. 2002, 62, 4316–4324. [PubMed]
5. Lee, K.; Qian, D.Z.; Rey, S.; Wei, H.; Liu, J.O.; Semenza, G.L. Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells. Proc. Natl. Acad. Sci. USA 2009, 106, 2353–2358. [CrossRef] [PubMed]
6. Müller, M.; Kersten, S. Nutrigenomics: Goals and strategies. Nat. Rev. Genet. 2003, 4, 315–322. [CrossRef] [PubMed]
7. Trayhurn, P. Nutritional genomics – “Nutrigenomics”. Br. J. Nutr. 2003, 89, 1–2. [CrossRef] [PubMed]
8. Chuaqui, R.F.; Bonner, R.F.; Best, C.J.M.; Gillespie, J.W.; Flaig, M.J.; Hewitt, S.M.; Phillips, J.L.; Krizman, D.B.; Tangrea, M.A.; Ahram, M.; et al. Post-analysis follow-up and validation of microarray experiments. Nat. Genet. 2002, 32, 509. [CrossRef] [PubMed]
9. Delcourt, C. Application of Nutrigenomics in Eye Health. In Forum of Nutrition; Karger Publishers: Basel, Switzerland, 2007; Volume 60, pp. 168–175. ISBN 1660-0347.
10. Fine, I.H. A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation with Vitamins C and E and Beta-Carotene for Age-Related Cataract and Vision Loss. Evidence-Based Eye Care 2003, 3, 80–81. [CrossRef]
11. Schalch, W.; Chylack, L.T. Antioxidative Mikronährstoffe und Katarakt. Der. Ophthalmol. 2003, 100, 181–189. [CrossRef]
12. Dátilo, M.N.; Sant’Ana, M.R.; Formigari, G.P.; Rodrigues, P.B.; de Moura, L.P.; da Silva, A.S.R.; Ropelle, E.R.; Pauli, J.R.; Cintra, D.E. Omega-3 from Flaxseed Oil Protects Obese Mice Against Diabetic Retinopathy Through GPR120 Receptor. Sci. Rep. 2018, 8, 1–13. [CrossRef] [PubMed]
13. Mori, K.; Kurihara, T.; Miyauchi, M.; Ishida, A.; Jiang, X.; Ikeda, S.; Torii, H.; Tsubota, K. Oral crocetin administration suppressed refractive shift and axial elongation in a murine model of lens-induced myopia. Sci. Rep. 2019, 9, 1–10. [CrossRef] [PubMed]
14. Pines, M.; Nagler, A. Halofuginone: A novel antifibrotic therapy. Gen. Pharmacol. 1998, 30, 445–450. [CrossRef]
15. McGaha, T.L.; Kodera, T.; Spiera, H.; Stan, A.C.; Pines, M.; Bona, C.A. Halofuginone inhibition of COL1A2 promoter activity via a c-Jun-dependent mechanism. Arthritis Rheum. 2002, 46, 2748–2761. [CrossRef] [PubMed]
16. Levi-Schaffer, F.; Nagler, A.; Slavin, S.; Knopov, V.; Pines, M. Inhibition of collagen synthesis and changes in skin morphology in murine graft-versus-host disease and tight skin mice: Effect of halofuginone. J. Invest. Dermatol. 1996, 106, 84–88. [CrossRef] [PubMed]
17. Sundrud, M.S.; Koralov, S.B.; Feuerer, M.; Calado, D.P.; Elhed, A.; Rhule-smith, A.; Lefebvre, R.E.; Unutmaz, D.; Waldner, H.; Whitman, M.; et al. Halofuginone inhibits TH17 cell differentiation by activating the amino acid starvation response. Science. 2010, 324, 1334–1338. [CrossRef] [PubMed]
18. Pines, M.; Halevy, O. Halofuginone and muscular dystrophy. Histol. Histopathol. 2011, 26, 135–146.
19. Nagler, A.; Ohana, M.; Shibolet, O.; Shapira, M.Y.; Alper, R.; Vlodavsky, I.; Pines, M.; Ilan, Y. Suppression of hepatocellular carcinoma growth in mice by the alkaloid coccidiostat halofuginone. Eur. J. Cancer 2004, 40, 1397–1403. [CrossRef]
20. Taras, D.; Blanc, J.-F.; Rullier, A.; Dugot-Senant, N.; Laurendeau, I.; Bièche, I.; Pines, M.; Rosenbaum, J. Halofuginone suppresses the lung metastasis of chemically induced hepatocellular carcinoma in rats through MMP inhibition. Neoplasia 2006, 8, 312–318. [CrossRef]
21. Gavish, Z.; Pinthus, J.H.; Barak, V.; Ramon, J.; Nagler, A.; Eshhar, Z.; Pines, M. Growth inhibition of prostate cancer xenografts by halofuginone. Prostate 2002, 51, 73–83. [CrossRef]
22. Gross, D.J.; Reibstein, I.; Weiss, L.; Slavin, S.; Dafni, H.; Neeman, M.; Pines, M.; Nagler, A. Treatment with Halofuginone Results in Marked Growth Inhibition of a von Hippel-Lindau Pheochromocytoma in vivo. Clin. Cancer Res. 2003, 9, 3788–3793. [PubMed]
23. Pinthus, H.J.; Sheffer, Y.; Nagler, A.; Fridman, E.; Mor, Y.; Genina, O.; Pines, M. Inhibition of Wilms tumor xenograft progression by halofuginone is accompanied by activation of WT-1 gene expression. J. Urol. 2005, 174, 1527–1531. [CrossRef] [PubMed]
24. Pines, M.; Snyder, D.; Yarkoni, S.; Nagler, A. Halofuginone to treat fibrosis in chronic graft-versus-host disease and scleroderma. Biol. Blood Marrow Transplant. 2003, 9, 417–425. [CrossRef]
25. 25. Onishi, S.; Meguro, S.; Pervin, M.; Kitazawa, H.; Yoto, A.; Ishino, M.; Shimba, Y.; Mochizuki, Y.; Miura, S.; Tokimitsu, I.; et al. Green Tea Extracts Attenuate Brain Dysfunction in High-Fat-Diet-Fed SAMP8 Mice. Nutrients 2019, 11, 821. [CrossRef] [PubMed]
26. Faggi, L.; Porrini, V.; Lanzillotta, A.; Benarese, M.; Mota, M.; Tsoukalas, D.; Parrella, E.; Pizzi, M. A Polyphenol-Enriched Supplement Exerts Potent Epigenetic-Protective Activity in a Cell-Based Model of Brain Ischemia. Nutrients 2019, 11, 345. [CrossRef] [PubMed]
27. Gorji, N.; Moeini, R.; Memariani, Z. Almond, hazelnut and walnut, three nuts for neuroprotection in Alzheimer’s disease: A neuropharmacological review of their bioactive constituents. Pharmacol. Res. 2018, 129, 115–127. [CrossRef] [PubMed]
28. Johnson, S.L.; Park, H.Y.; Dasilva, N.A.; Vattem, D.A.; Ma, H.; Seeram, N.P. Levodopa-reduced mucuna pruriens seed extract shows neuroprotective effects against parkinson’s disease in murine microglia and human neuroblastoma cells, Caenorhabditis elegans, and Drosophila melanogaster. Nutrients 2018, 10, 1139. [CrossRef] [PubMed]
29. Altieri, F.; Cairone, F.; Giamogante, F.; Carradori, S.; Locatelli, M.; Chichiarelli, S.; Cesa, S. Influence of Ellagitannins Extracted by Pomegranate Fruit on Disulfide Isomerase PDIA3 Activity. Nutrients 2019, 11, 186. [CrossRef]
30. Locri, F.; Cammalleri, M.; Pini, A.; Dal Monte, M.; Rusciano, D.; Bagnoli, P. Further Evidence on Efficacy of Diet Supplementation with Fatty Acids in Ocular Pathologies: Insights from the EAE Model of Optic Neuritis. Nutrients 2018, 10, 1447. [CrossRef]
31. Lu, C.; Wang, Y.; Wang, D.; Zhang, L.; Lv, J.; Jiang, N.; Fan, B.; Liu, X.; Wang, F. Neuroprotective effects of soy isoflavones on scopolamine-induced amnesia in mice. Nutrients 2018, 10, 853. [CrossRef] [PubMed]
32. Miwa, Y.; Hoshino, Y.; Shoda, C.; Jiang, X.; Tsubota, K.; Kurihara, T. Pharmacological HIF inhibition prevents retinal neovascularization with improved visual function in a murine oxygen-induced retinopathy model. Neurochem. Int. 2019, 128, 21–31. [CrossRef] [PubMed]
33. Ahmed, A.; Wang, L.L.; Abdelmaksoud, S.; Aboelgheit, A.; Saeed, S.; Zhang, C.L. Minocycline modulates microglia polarization in ischemia-reperfusion model of retinal degeneration and induces neuroprotection. Sci. Rep. 2017, 7, 1–16. [CrossRef] [PubMed]
34. Schultz, R.; Krug, M.; Precht, M.; Wohl, S.G.; Witte, O.W.; Schmeer, C. Frataxin overexpression in Müller cells protects retinal ganglion cells in a mouse model of ischemia/reperfusion injury in vivo. Sci. Rep. 2018, 8, 1–15. [CrossRef] [PubMed]
論文の公開元へ
